Biblio

2024
Sheikh IN, Okeleji O, Afzal R, Bonfante E, Kodakandla M, Menon NM. Recurrent Nontraumatic Subgaleal Hematomas in a Pediatric Patient With Sickle Cell Disease. J Pediatr Hematol Oncol. 2024.
Yaguchi A, Fujimura J, Maruyama K, Fujiwara M, Ishibashi T, Tomita O, Shimizu T. Recurrent spinal atypical teratoid/rhabdoid tumor with pulmonary metastasis. Cancer Rep (Hoboken). 2024:e1975.
De Jesus DF, Zhang Z, Brown NK, Li X, Xiao L, Hu J, Gaffrey MJ, Fogarty G, Kahraman S, Wei J, et al. Redox regulation of mA methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes. Nat Cell Biol. 2024.
Jiang H, Nechipurenko DYu, Panteleev MA, Xu K, Qiao J. Redox regulation of platelet function and thrombosis. J Thromb Haemost. 2024.
Tang J, Jensen RR, Bryan B, Hoda D, Hunter BD. reduced Cytokine Release Syndrome and improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell Transplant. Transplant Cell Ther. 2024.
Bazinet A, Kantarjian H, Bataller A, Pemmaraju N, Borthakur G, Chien K, Alvarado Y, Bose P, Jabbour E, Yilmaz M, et al. Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial. Lancet Haematol. 2024;11(4):e287-e298.
Niederwieser C, Iacobelli S, Franke G-N, Koster L, van Os M, Platzbecker U, Hübel K, Scheid C, Müller LPeter, Stelljes M, et al. Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC). Bone Marrow Transplant. 2024.
van Berkel AArienne, Lammertse HCharlotte, Öttl M, Koopmans F, Misra-Isrie M, Meijer M, Dilena R, van Hasselt PMarin, Engelen M, van Haelst M, et al. Reduced MUNC18-1 Levels, Synaptic Proteome Changes, and Altered Network Activity in -Related Disorder Patient Neurons. Biol Psychiatry Glob Open Sci. 2024;4(1):284-298.
Webbers SDs, Aarts CEm, Klein B, Koops D, Geissler J, Tool ATj, van Bruggen R, van den Akker E, Kuijpers TW. Reduced myeloid commitment and increased uptake by macrophages of stem cell-derived HPS2 neutrophils. Life Sci Alliance. 2024;7(4).
Park S, Bang S-Y, Kwag D, Lee JHyuk, Kim TYoon, Lee J, Min GJune, Park SSoo, Yahng S-A, Jeon Y-W, et al. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone Marrow Transplant. 2024.
Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS. Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol. 2024;15:1369243.
Soomann M, Prader S, Monteiro APinto, Zeilhofer U, Hauri-Hohl M, Güngör T, Schmid JPachlopnik, Trück J, Felber M. Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening. J Clin Immunol. 2024;44(1):39.
Wildey A, Harrington S, Stehno-Bittel L, Karanu F. Reduction of Activin A gives rise to comparable expression of key definitive endoderm and mature beta cell markers. Regen Med. 2024.
Wijaya CSugiarto, Xu S. Reevaluating Golgi fragmentation and its implications in wound repair. Cell Regen. 2024;13(1):4.
Nookaew I, Xiong J, Onal M, Bustamante-Gomez C, Wanchai V, Fu Q, Kim H-N, Almeida M, O'Brien CA. Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone. J Biol Chem. 2024:107158.
Zhang R, Zhao X, Li W, Gao Y. Refractory Anti-N-Methyl-d-Aspartate Receptor Autoimmune Encephalitis Induced by Ovarian Teratoma: A Case Report. Clin Neuropharmacol. 2024.
Malfona F, Testi AMaria, Chiaretti S, Moleti MLuisa. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies. Blood Lymphat Cancer. 2024;14:1-15.
Pando-Caciano A, Escudero-Ramirez KAdid, Torres-Rodríguez JCarol, Maita-Malpartida H. Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report. Front Med (Lausanne). 2024;11:1335969.
Parain K, Chesneau A, Locker M, Borday C, Perron M. Regeneration from three cellular sources and ectopic mini-retina formation upon neurotoxic retinal degeneration in Xenopus. Glia. 2024.
Kobayashi H, Tohyama S, Ichimura H, Ohashi N, Chino S, Soma Y, Tani H, Tanaka Y, Yang X, Shiba N, et al. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids. Circulation. 2024.
Lath YV, Thool AR, Jadhav I. Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review. Cureus. 2024;16(2):e53479.
Seker S, Lalegül-Ülker Ö, Elcin AEser, Elçin YMurat. Regeneration of Volumetric Muscle Loss Using MSCs Encapsulated in PRP-Derived Fibrin Microbeads. Methods Mol Biol. 2024.
Shrestha S, Acharya P, Kang S-Y, Vanga MGoud, Lekkala VKumar Redd, Liu J, Yang Y, Joshi P, Lee M-Y. Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays. bioRxiv. 2024.
Foti C, Vellucci C, Santoro A. Regenerative Medicine Solutions for Rotator Cuff Injuries in Athletes: Indications and Outcomes. Sports Med Arthrosc Rev. 2024;32(1):46-50.
Leng W, Li X, Dong L, Guo Z, Ji X, Cai T, Xu C, Zhu Z, Lin J. The Regenerative Microenvironment of the Tissue Engineering for Urethral Strictures. Stem Cell Rev Rep. 2024.

Pages